Generated by DeepSeek V3.2| American Type Culture Collection | |
|---|---|
| Name | American Type Culture Collection |
| Founded | 0 1925 |
| Location | Manassas, Virginia, United States |
| Key people | Raymond C. Bard (First Director) |
| Focus | Biological resource center, microbiology, cell biology |
American Type Culture Collection. It is a premier global nonprofit biological resource center and research organization dedicated to the acquisition, authentication, production, preservation, development, and distribution of standard reference microorganisms, cell lines, and other materials for research. Established in the mid-1920s, it serves as an indispensable repository for scientists in academia, industry, and government, supporting advancements across biomedical research, pharmaceutical development, and public health. Its collections are critical for ensuring the reproducibility of scientific studies and for providing the foundational biological materials that drive discovery in fields like infectious disease and biotechnology.
The organization was founded in 1925 by a committee of scientists from the National Research Council and the Society of American Bacteriologists, responding to a critical need for reliable, uncontaminated microbial strains for research and teaching. Its early development was significantly influenced by the work of Robert S. Breed and other prominent microbiologists. Initially housed at McCormick & Company in Baltimore, its first major curator was Raymond C. Bard. A pivotal moment in its early history was its role in supplying strains for penicillin research during World War II, cementing its importance to national scientific infrastructure. It later moved to Georgetown University and then to Rockville, Maryland, before establishing its current, larger campus in Manassas, Virginia.
The repository maintains one of the world's most diverse and extensive collections of biological reference materials. This includes over 75,000 authenticated strains of bacteria, fungi, yeast, viruses, and protozoa, as well as more than 4,000 human, animal, and plant cell lines. Notable holdings include the original HeLa cell line, key strains used in developing the polio vaccine, and type strains for bacterial taxonomy. It also houses genomic materials like DNA clones and libraries, along with specialized collections such as the NIH AIDS Research and Reference Reagent Program repository. These materials are meticulously preserved using techniques like cryopreservation and lyophilization.
Beyond repository functions, it conducts vital research in microbiology, cell biology, and biobanking science. Its scientists work on projects related to biosafety, strain characterization, microbial pathogenesis, and the development of standards for biological materials. Core services provided to the global scientific community include the distribution of cultures, cell culture and microbial culture training programs, and contract research for pharmaceutical companies and government agencies like the Centers for Disease Control and Prevention. It also offers advanced services in DNA sequencing, microbial identification, and mycoplasma testing to ensure cell line purity.
As a private, nonprofit organization, it is governed by a Board of Directors composed of leaders from academia, industry, and public health. Operational funding is derived from a combination of revenue from culture sales and service contracts, federal grants from agencies such as the National Institutes of Health and the National Science Foundation, and support from private foundations. This diversified financial model supports its mission-driven activities, including maintaining its vast collections, conducting independent research, and participating in global initiatives like the World Federation for Culture Collections.
Its impact on global science is profound, underpinning decades of reproducible research in infectious diseases, cancer, vaccinology, and genomics. It is recognized as an International Depository Authority under the Budapest Treaty for patent purposes. Its reference materials are cited in thousands of scientific papers annually and have been crucial in responding to public health crises, from HIV/AIDS to COVID-19, by providing essential research strains. The organization's commitment to quality and accessibility has made it a trusted partner for institutions worldwide, including the World Health Organization and the European Centre for Disease Prevention and Control.
Category:Biotechnology organizations Category:Microbiology organizations Category:Scientific organizations based in the United States